PAK2 and prostate cancer: Elevated PAK1 protein levels are associated with colorectal, hepatocellular, and prostate cancer metastasis, and PAK2 and 6 overexpression is linked to chemotherapeutic and radiation resistance in breast and prostate cancers, respectively [37-42].